Cargando…
Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations
BACKGROUND: Mucolipidosis type II (MLII), or I-cell disease, is a rare lysosomal storage disease (LSD) caused by variants in the GNPTAB gene. MLII patients exhibit clinical phenotypes in the prenatal or neonatal stage, such as marked dysmorphic features, cardiac involvement, respiratory symptoms, dy...
Autores principales: | He, Si-jia, Li, Dong-jun, Lv, Wen-qiong, Tang, Wen-hao, Sun, Shu-wen, Zhu, Yi-ping, Liu, Ying, Wu, Jin, Lu, Xiao-xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359890/ https://www.ncbi.nlm.nih.gov/pubmed/37484777 http://dx.doi.org/10.3389/fped.2023.1199489 |
Ejemplares similares
-
Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
por: Mao, Shao-Jia, et al.
Publicado: (2022) -
Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
por: Essawi, Mona L., et al.
Publicado: (2021) -
A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease)
por: Wang, Ping, et al.
Publicado: (2018) -
Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017) -
Neonatal mucolipidosis type II alpha/beta due to compound heterozygosity for a known and novel GNPTAB mutation, and a concomitant heterozygous change in SERPINF1 inherited from the mother
por: Wood, Kirsten A., et al.
Publicado: (2017)